CalciMedica (CALC) Stock Chart & Stock Price History $1.76 -0.05 (-2.76%) As of 10:50 AM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock CalciMedica Stock Price Performance The CalciMedica (CALC) stock chart highlights key performance trends across multiple timeframes. Over the last 12 months, the stock's price has decreased 65.22%, with a year-to-date return of -50.28%. In the past month, the stock has decreased 12.44%, reflecting recent market activity. As of the latest close, CalciMedica traded at $1.81 with a market cap of $25.29 million and volume of 15,183 shares. Receive CALC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CalciMedica and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.15%1 Month Performance-12.44%3 Month Performance-8.33%Year-To-Date Performance-50.28%1 Year Performance-65.22% CALC Stock Chart for Thursday, June, 12, 2025 CALC Chart by TradingView CalciMedica Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization06/11/2025$1.85$1.81-2.16%$1.89$1.8015,183 shs$25.29 million06/10/2025$1.79$1.85+3.35%$1.90$1.8325,503 shs$25.85 million06/09/2025$1.74$1.79+2.87%$1.89$1.7815,943 shs$25.01 million06/06/2025$1.68$1.74+3.58%$1.87$1.7028,123 shs$24.31 million06/05/2025$1.72$1.68-2.05%$1.74$1.6627,075 shs$23.47 million06/04/2025$1.63$1.72+5.21%$1.72$1.6611,965 shs$23.96 million06/03/2025$1.64$1.63-0.61%$1.71$1.6130,324 shs$22.77 million06/02/2025$1.66$1.64-1.47%$1.73$1.6413,942 shs$22.91 million05/30/2025$1.75$1.66-4.68%$1.71$1.654,614 shs$23.26 million05/29/2025$1.74$1.75+0.13%$1.76$1.6924,011 shs$24.40 million Get the Latest News and Ratings for CALC and Related StocksEnter your email address below to receive the latest news and analysts' ratings for CalciMedica and its competitors with MarketBeat's FREE daily newsletter. 05/28/2025$1.76$1.74-0.91%$1.79$1.728,837 shs$24.37 million05/27/2025$1.80$1.76-2.22%$1.83$1.7411,759 shs$24.59 million05/26/2025$1.80$1.80$1.80$1.713,846 shs$25.15 million05/23/2025$1.68$1.80+7.08%$1.80$1.713,846 shs$25.15 million05/22/2025$1.75$1.68-3.94%$1.78$1.6615,001 shs$23.49 million05/21/2025$1.86$1.75-5.91%$1.90$1.7534,456 shs$24.45 million05/20/2025$1.86$1.86$1.91$1.8017,837 shs$25.99 million05/19/2025$2.00$1.86-7.00%$2.00$1.8521,546 shs$25.99 million05/16/2025$1.94$2.00+3.09%$2.04$1.9121,822 shs$27.94 million05/15/2025$1.91$1.94+1.41%$2.00$1.9037,623 shs$27.11 million05/14/2025$1.93$1.91-0.88%$2.04$1.8778,841 shs$26.73 million05/13/2025$2.01$1.93-3.98%$2.04$1.8633,742 shs$26.97 million05/12/2025$2.00$2.01+0.50%$2.02$1.9321,656 shs$28.08 million Related Companies C4 Therapeutics Stock Price Chart Anixa Biosciences Stock Price Chart Coya Therapeutics Stock Price Chart Milestone Pharmaceuticals Stock Price Chart Genelux Stock Price Chart Zentalis Pharmaceuticals Stock Price Chart OncoCyte Stock Price Chart Caribou Biosciences Stock Price Chart Lexeo Therapeutics Stock Price Chart Corbus Pharmaceuticals Stock Price Chart Receive CALC Stock News and Ratings via EmailSign-up to receive the latest news and ratings for CalciMedica and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:CALC) was last updated on 6/12/2025 by MarketBeat.com Staff From Our PartnersTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredBig Changes Coming to Social Security?According to legendary investor Louis Navellier... This new Trump move could soon not only save Social Secu...InvestorPlace | SponsoredSHOCKING: Musk's Pentagon Secret Mission...It's about a harrowing message discovered on December 16, 2024: "美国军方暗杀名单" It's the reason President Tru...Behind the Markets | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredThe one deadline Elon can't afford to miss...For years, Elon Musk made headlines for blowing past deadlines — so often that investors coined a nickname for...Brownstone Research | SponsoredAn AI run of epic proportions is only getting startedI just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding CalciMedica, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share CalciMedica With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Buy CALC Stock Free CALC Stock Alerts